An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) stock is trading lower on Monday. On Friday, during after-hours trading, Pliant ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...

Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.

Fintel reports that on February 10, 2025, HC Wainwright & Co. downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX ...

Pliant Therapeutics has pumped the breaks on a mid-stage trial of its lead liver disease drug on the advice of its safety ...

(Nasdaq: MIRM) today announced that on February 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted ...

HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a report published on Friday,Benzinga reports. HC Wainwright currently has a $13.00 price target on the stock ...

This segment is sponsored by Mirum Pharmaceuticals, Inc.What does itching have to do with your liver?It's one of the primary symptoms of a rare, progressive li ...

In this referral centre based study, inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD) was characterised by a high prevalence of pancolitis with rectal sparing and ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).